Skip to main content
Year archive

KYONGBO PHARMACEUTICAL CO., LTD. — 2023 filings

All 21 regulatory filings released by KYONGBO PHARMACEUTICAL CO., LTD. (214390) in 2023, sourced directly from the official regulator.

21 Filings
2023 Period
2023 filings (21)
Filing Released Lang
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Q3 2023
2023-10-27 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-11 Korean
영업(잠정)실적(공정공시)
Earnings Release H1 2023
2023-07-28 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2023
2023-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-03-24 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2023-03-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-03-24 Korean
최대주주등소유주식변동신고서
Director's Dealing
2023-03-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-14 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-02-22 Korean
[기재정정]주주총회소집공고
AGM Information
2023-02-21 Korean
주주총회소집공고
AGM Information
2023-02-20 Korean
주주총회소집결의
AGM Information
2023-02-15 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2023-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2022
2023-01-30 Korean